4.5 Review

Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 64, Issue -, Pages S365-S378

Publisher

IOS PRESS
DOI: 10.3233/JAD-179917

Keywords

3xTg-AD; amyloid-beta; animal models; comorbidities; inflammation; stem cell therapy; synaptic loss; tau

Categories

Funding

  1. Alzheimer's Association [NIRG-15-363477, AARF-16-440760]
  2. Larry Hillblom Foundation [2013-A-016-FEL, 2016-A-016-FEL]
  3. National Institute of Health (NIH) NIH/NIA [AG027544, AG00538, AG054 884]
  4. Bright Focus Foundation [A201 5535S]

Ask authors/readers for more resources

Alzheimer's disease (AD) impairs memory and causes significant cognitive deficits. The disease course is prolonged, with a poor prognosis, and thus exacts an enormous economic and social burden. Over the past two decades, genetically engineered mouse models have proven indispensable for understanding AD pathogenesis, as well as for discovering new therapeutic targets. Here we highlight significant studies from our laboratory that have helped advance the AD field by elucidating key pathogenic processes operative in AD and exploring a variety of aspects of the disease which may yield novel therapeutic strategies for combatting this burdensome disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available